secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0001062822-25-000035
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon gets Nasdaq 180-day extension to regain $1 bid; stock moves to Capital Market
--------------------------------------------------------------------------------

- Nasdaq granted additional 180-day period until Dec 30, 2025 for Lexicon to cure $1 bid price deficiency.
- Common stock will transfer from Nasdaq Global Select to Capital Market on July 7, 2025.
- Compliance requires closing bid ≥ $1 for ten consecutive business days during the extension period.
- Eligibility conditioned on meeting other listing requirements and intent to pursue reverse stock split if necessary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282225000035/0001062822-25-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282225000035/lxrx-20250703.htm
  HTML page:      https://secwatch.observer/filing/0001062822-25-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer